Evidence map›Paper›PMID 36350811›Full record

ArticlePloS one2022

Predicting prediction: A systematic workflow to analyze factors affecting the classification performance in genomic biomarker discovery.

Michael Netzer, Christian Baumgartner, Daniel Baumgarten

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael NetzerInstitute of Electrical and Biomedical Engineering, UMIT - Private University For Health Sciences and Health Technology, Hall in Tirol, Austria.ORCID 0000-0001-7536-9257
Christian BaumgartnerInstitute of Electrical and Biomedical Engineering, UMIT - Private University For Health Sciences and Health Technology, Hall in Tirol, Austria.
Daniel BaumgartenInstitute of Electrical and Biomedical Engineering, UMIT - Private University For Health Sciences and Health Technology, Hall in Tirol, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High throughput technologies in genomics enable the analysis of small alterations in gene expression levels. Patterns of such deviations are an important starting point for the discovery and verification of new biomarker candidates. Identifying such patterns is a challenging task that requires sophisticated machine learning approaches. Currently, there are a variety of classification models, and a common approach is to compare the performance and select the best one for a given classification problem. Since the association between the features of a data set and the performance of a particular classification method is still not fully understood, the main contribution of this work is to provide a new methodology for predicting the prediction results of different classifiers in the field of biomarker discovery. We propose here a three-steps computational workflow that includes an analysis of the data set characteristics, the calculation of the classification accuracy and, finally, the prediction of the resulting classification error. The experiments were carried out on synthetic and microarray datasets. Using this method, we showed that the predictability strongly depends on the discriminatory ability of the features, e.g., sets of genes, in two or multi-class datasets. If a dataset has a certain discriminatory ability, this method enables prediction of the classification performance before applying a learning model. Thus, our results contribute to a better understanding of the relationship between dataset characteristics and the corresponding performance of a machine learning method, and suggest the optimal classification method for a given dataset based on its discriminatory ability.

Indexed as

Gene Expression ProfilingGenomicsBiomarkers, TumorMachine LearningWorkflowBiomarkers, Tumor

Identifiers

PMID36350811
PMCPMC9645616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.